Crossmark

PCSK9 inhibitors: A new improvement for health

Crossref DOI link: https://doi.org/10.1016/j.artere.2018.11.005

Published Print: 2019-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Perelló Camacho, Eva
License Information

Text and Data Mining valid from 2019-09-01
More Information

This article is maintained by: Elsevier

Article Title: PCSK9 inhibitors: A new improvement for health

Journal Title: Clínica e Investigación en Arteriosclerosis (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.artere.2018.11.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arteri.2018.11.001

Content Type: article

Copyright: © 2019 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Arteriosclerosis.